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Neutral lipid storage disease with ichthyosis (NLSDI; Chanarin–Dorfman syndrome) is an ichthyosiform
syndrome, often associated with mutations in a lipid hydrolase, CGI-58. The presence of oil red O-positive,
neutral lipid droplets in tissue biopsies, and/or in leukocytes on blood smears, coupled with a constellation of
multisystem abnormalities and a pruritic ichthyosiform erythroderma, are together diagnostic of NLSDI. We
investigated the pathogenesis of the ichthyosiform erythroderma in patients from three unrelated kindreds
with a clinical diagnosis of NLSDI. Basal permeability barrier function and stratum corneum (SC) integrity were
abnormal, but barrier recovery rates were faster than normal, as in atopic dermatitis. The basal barrier
abnormality was linked to the secretion of lipid micro-inclusions, first segregated within lamellar bodies (LB),
which then form a non-lamellar phase within the SC interstices, shown by combined ruthenium tetroxide post-
fixation and lipid-retaining resin-white embedding. With colloidal lanthanum nitrate perfusion, excess water/
solute movement was restricted to the SC interstices, and further localized to non-lamellar domains. Phase
separation of excess stored lipid provides a unifying pathogenic mechanism not only for NLSDI, but also in
several other inherited ichthyosiform disorders of lipid metabolism, such as recessive X-linked ichthyosis and
type 2 Gaucher’s disease.
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INTRODUCTION
Neutral lipid storage disease with ichthyosis (NLSDI), or
Chanarin–Dorfman syndrome (online Mendelian inheritance
in man no. 275630), is a rare, recessive disorder often owing
to mutations in a hydrolase, CGI-58 (Lefevre et al., 2001;
Akiyama et al., 2003). In NLSDI, triacylglycerols (TAGs)
accumulate in cytosolic droplets in multiple tissues, allowing
a rapid, unambiguous clinical diagnosis by oil red O staining
of frozen tissue sections (Figure 1), or by visual inspection of
blood smears (Elias and Williams, 1985; Williams et al.,
1985). Although the ichthyosiform phenotype in NLSDI is
nonspecific, most closely resembling non-bullous congenital
ichthyosiform erythroderma, patients often experience prur-
itus, with or without atopic features (Williams et al., 1985)
(Figure S1). Biopsies of affected skin demonstrate lipid
droplets, most prominently in the epidermal basal layer and
in appendageal epithelia (Elias and Williams, 1985). How-
ever, such storage vacuoles are not likely to account for the
ichthyosiform phenotype in NLSDI, because cytosolic inclu-
sions become entombed within corneocytes, where they
cannot influence inherently extracellular functions, such as
permeability barrier homeostasis or desquamation. More-
over, comparable cytosolic lipid droplets occur as a non-
specific response to toxic insults, as well as in many hyper-
plastic dermatoses (Zaynoun et al., 1983; Johnson et al., 1987;
Kanerva, 1990; El-Shoura and Tallab, 1997; Monteiro-Riviere
et al., 2004).
More pertinent to disease phenotype instead could be the
small, amorphous, lipid micro-inclusions within epidermal
lamellar bodies (LBs), which are secreted, along with lamellar
membranes, at the stratum granulosum (SG)/stratum corneum
(SC) interface (Elias and Williams, 1985). Accordingly, LB
encapsulate several types of lipase activity (Menon et al.,
1992; Elias et al., 1998; Rassner et al., 1999), including the
hydrolase encoded by CGI-58 (Yamaguchi et al., 2004).
Therefore, the enzyme mutation and the lipid micro-
inclusions in NLSDI could be linked to disease pathogenesis
first, through their colocalization within LB; and then,
through the persistence of secreted, undegraded TAGs within
the SC interstices.
We hypothesized previously that the ichthyosiform
erythroderma in congenital ichthyosiform erythroderma,
and presumably in NLSDI, as well, could be driven by a
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permeability barrier abnormality (Williams, 1992). Normal
LBs are replete with lamellar membranes, showing no
evidence of non-lamellar lipid micro-inclusions. Following
secretion, these membranes normally pack the SG–SC inter-
face, where they transform into the ‘‘mature’’ lamellar
membrane structures that regulate permeability barrier
homeostasis, which again fill the SC interstices (Elias and
Menon, 1991). A uniform lamellar phase, which completely
fills the SC interstices, therefore equates to permeability
barrier competence (Elias and Menon, 1991). In contrast, in
NLSDI, we proposed previously that the secreted lipid micro-
inclusions transform into electron-lucent, lipid-filled ‘‘clefts’’,
which could lead to the ichthyosiform dermatosis (Elias and
Williams, 1985). But in these earlier studies, the contents of
these ‘‘clefts’’ could not be visualized owing to prior reliance
on osmium fixation; and therefore, they could not be
distinguished from the artifact that frequently accompanies
tissue processing. If lipids are present within these ‘‘clefts’’,
they could reflect lamellar/non-lamellar phase separation
within the SC interstices, which would form an inherently
less-effective permeability barrier than that provided by
interstices uniformly replete with lamellar membranes. We
asked here first, whether a permeability barrier abnormality
exists in NLSDI; second, whether the putative barrier
abnormality is linked to lamellar/non-lamellar phase separa-
tion of extracellular lipids; and third, whether these structural
changes specifically lead to the permeability barrier abnorm-
ality.
RESULTS AND COMMENTS
The diagnosis of NLSDI is based upon a characteristic and
diagnostic spectrum of clinical and histochemical features
(Williams et al., 1985). Although recently attributed to
mutations in CGI-58, a lipid hydrolase (Lefevre et al., 2001;
Akiyama et al., 2003), mutations in this gene are not
invariably found in clinically typical patients (G. Richard,
personal communication). The pathway that leads to
cytosolic TAG accumulation is not known with certainty.
However, labeling studies suggest that the lipolytic activity
that utilizes diacylglycerols derived from TAG for phospho-
lipids synthesis is impaired, resulting in TAG accumulation in
NLSDI (Williams et al., 1991; Igal and Coleman, 1996,
1998).
The issue we addressed here is how a defect in TAG
metabolism can provoke an ichthyosifrom erythroderma.
Basal transepidermal water loss (TEWL) values for the patient
from one of the new NLSDI kindreds (patient no. 2) were
compared with similarly obtained, functional data from
normal, age- and gender-matched, historical controls. De-
pending upon body site, basal TEWL levels were up to three-
fold higher in NLSDI than in age-matched normal controls
(Figure 2a). These water loss levels are comparable to those
reported for other ichthyoses with a similar phenotype
(congenital ichthyosiform erythroderma and transglutaminase
1-negative lamellar ichthyosis) (Lavrijsen et al., 1995; Elias
et al., 2004; Moskowitz et al., 2004). Although basal TEWL
levels were increased in NLSDI, barrier recovery kinetics after
tape stripping were more rapid in NLSDI than in control skin
(Figure 2b). Yet, despite accelerated recovery rates, barrier
function never declined to normal levels. Thus, NLSDI
resembles atopic dermatitis, not only in some of its clinical
features but also in the phenomenon of accelerated barrier
recovery kinetics, with failure of barrier function to attain
normal competence, despite accelerated recovery rates
(Seidenari and Giusti, 1995; Gfesser et al., 1997). Moreover,
both SC integrity, assessed as the rate that TEWL levels
increase with sequential D-squames tape strippings, and SC
cohesion (amount of protein removed per stripping) were
impaired in NLSDI in comparison to normal, control subjects
(Figure 2c and d). The abnormality in SC integrity and
cohesion likely reflects elevated pH of affected SC, which
would activate serine proteases, such as kallikrein 5 and 7,
which mediate desquamation (Hachem et al., 2003; Caubet
et al., 2004). However, this study did not address mechan-
isms responsible for the desquamation abnormality in NLSDI.
We next assessed the structural basis for the barrier
abnormality in NLSDI. Psoriasiform epidermal hyperplasia
was observed in skin biopsies from both patients (nos. 1 and
2) (Figure 1c and d), as previously shown for the first kindred
(Elias and Williams, 1985). As shown in prior ultrastructural
studies of the first kindred (Elias and Williams, 1985),
epidermal LB in patient nos. 1 and 2 again contained lipid
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Figure 1. Lipid micro-inclusions in NLSDI. (a, arrows) Lipid droplets are visualized in polynuclear cells on a blood smear as empty vacuoles. In the epidermis,
after oil red O staining, lipid cytoplasmic micro-inclusions are found in basal keratinocytes (arrows; (b) section of the epidermis in frozen sections, with
hematoxylin counterstain). Epidermal hyperplasia can be seen in both skin biopsies of patient nos. 1 and 2 on (c and d) toluidine blue-stained sections in
comparison to (e) site- and aged-matched control. (SC: stratum corneum; SG: stratum granulosum; SS: stratum spinosum; SB: stratum basal.)
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micro-inclusions, which were co-secreted with lamellar
contents, at the SG–SC interface (Figure 3). Higher magnifica-
tion images revealed first that most of these inclusions were
membrane bound (Figure 3a and b, black arrows), and that
these inclusions remained membrane bound following their
initial secretion at the SG–SC interface (Figure 3a, black
arrows). Despite abnormal LB contents, secretion of organelle
content was normal in all of our patients, evidenced by lack
of retained LB contents within corneocytes. Thus, NLSDI
differs from other types of ichthyoses (e.g., epidermolytic
hyperkeratosis), where LB secretion is impaired (Schmuth
et al., 2001).
Standard osmium tetroxide post-fixation, followed by
Epon–epoxy embedding, demonstrated electron-lucent
‘‘clefts’’ initially within the SG–SC interface, and elsewhere
within the SC interstices, where these clefts aligned
horizontally above parallel arrays of normal-appearing
lamellar membranes (Figure 4), as noted previously (Elias
and Williams, 1985). Yet, whether these ‘‘clefts’’ are
artifactual, or whether they contain stored lipid could not
be ascertained using this standard protocol. To delineate
whether these clefts contain phase-separated (non-lamellar)
lipid, we next assessed the parallel samples after ruthenium
tetroxide post-fixation, a method that allows visualization of
hydrophobic lipid structures, such as the extracellular
lamellar membranes (Swartzendruber et al., 1995), coupled
with embedding in a lipid-retaining resin-white. Using this
method, the ‘‘clefts’’ did not appear empty, but rather filled
with an amorphous, electron-dense material, adjacent to
arrays of lamellar membranes (Figure 5a). These results show
that the secreted, LB-derived, lipid micro-inclusions in NLSDI
form a non-lamellar phase within the SC interstices. Lamellar/
non-lamellar phase separation occurs in polar lipid-based,
membrane bilayers, when the amount of nonpolar lipid
exceeds the capacity of the membrane to incorporate this
lipid (Bangham, 1972; Rehfeld et al., 1986, 1988). Typical,
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Figure 2. NLSDI displays abnormalities in barrier homeostasis and SC
integrity/cohesion. (a) TEWL rates from patient no. 2 at baseline, before
barrier disruption, were up to three-fold higher than seen in aged-matched
historical controls (Seidenari and Giusti, 1995) (horizontal dashed line) (mean
age 572). (b) Barrier recovery after tape stripping in the patient of the new
kindred compared to recovery in controls (historical controls in grey boxes). (c)
Evaluation of epidermal barrier integrity expressed by TEWL after sequential
tape-stripping using D-squamess. Normal values are shown in striped boxes
(historical controls from adults). (d) Cohesion: total amount of protein removed
per D-squamess (sum of 10 sequential D-squamess shown) on five different
body sites (horizontal line: historical controls) (1: back; 2–6: forearms).
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Figure 3. Electron micrographs showing the clefts’ at the SC/SG interface.
(a) White arrows; aged-matched-control is shown in black bordered inset,
black arrows. Lipid micro-inclusions (asterisks) appear within the (a–e)
lamellar bodies, which are (a and b, black arrows) membrane bound.
Bars: 100 nm.
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phospholipid-based membrane bilayers display a very limited
capacity to incorporate nonpolar species, such as TAGs or
cholesterol esters. Our results suggest that ceramide-based
membrane bilayers likewise can only incorporate a limited
amount of nonpolar lipids, such as the accumulating TAGs in
NLSDI.
Finally, we assessed whether lamellar/non-lamellar phase
separation accounts for the permeability barrier abnormality
in NLSDI. While the interstices of normal human SC
completely exclude the water-soluble, electron-dense tracer,
lanthanum nitrate (Elias et al., 1977), tracer could be
visualized within the extracellular spaces at all levels of the
SC in NLSDI, where it further localized to non-lamellar
domains (Figure 5b). In contrast, lanthanum was largely
excluded from lamellar domains, demonstrating that water
and solute movement occurs preferentially through non-
lamellar domains in NLSDI. Thus, this structural feature, that
is, lamellar/non-lamellar phase separation, underlies the
permeability barrier abnormality in NLSDI.
NLSDI represents just one of several lipid metabolic
disorders with ichthyosis that could display a common
mechanism of lamellar/non-lamellar phase separation as the
basis for the barrier abnormality (and phenotype) in these
disorders. Pertinently, phase separation of another accumu-
lated lipid, cholesterol sulfate, has been shown to account for
the barrier abnormality in recessive X-linked ichthyosis
(Zettersten et al., 1998; Elias et al., 2004). Biophysical studies
showed that an excess of this polar lipid cannot be
completely incorporated into a lamellar lipid phase, consist-
ing of the SC lipids, cholesterol, and free fatty acids (Rehfeld
et al., 1986; Table 1). Moreover, the barrier abnormality in
type 2 Gaucher disease can also be attributed, at least in part,
to accumulation of phase-separated glucosylceramides in the
SC interstices (Holleran et al., 1994). Pertinently, phase
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Figure 4. Electron micrograph of epidermis after osmium tetroxide
post-fixation and Epon–epoxy embedding. Arrows show empty ‘‘clefts’’
at the SC/SG interface and above lamellar material in the SC interstices.
Asterisks indicate lipid droplets within the corneocytes. (a and b) Osmium
tetroxide post-fixation. Control, normal epidermis: cf. Figure 3a (inset) and
Elias and Williams (1985). Bars: 500 nm.
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Figure 5. Electron micrographs after ruthenium tetroxide post-fixation
coupled with lipid-retaining resin-white embedding. (a and b) Amorphous
electron-dense material forming the non-lamellar phase in the ‘‘clefts’’
(asterisks) adjacent to normal-appearing lamellae (white arrows). The
electron-dense tracer, lanthanum nitrate, is excluded from lamellar domains,
but can be seen within adjacent non-lamellar domains in the SC interstices
((c), ruthenium tetroxide post-fixation, Epon embedded). Bars: 100 nm.
Table 1. Ichthyoses that have or could have lamellar phase separation as basis for barrier abnormality
Disease Enzymatic defect Barrier dysfunction
Lamellar/non-lamellar
phase separation Phase-separated lipid
Neutral lipid storage disease Hydrolase (CGI-58) Demonstrated1 Demonstrated1 Triglycerides
Recessive X-linked ichthyosis Steroid sulfatase Demonstrated2 Demonstrated2 Cholesterol sulfate
Refsum’s disease Phytanoyl-CoA hydroxylase (PhyH) Not assessed Not assessed Phytanic acid in all
glycerolipids3
Sjogren–Larsson Fatty aldehyde deshydrogenase Not assessed Demonstrated4 Not assessed
Gaucher disease b-Glucocerebrosidase Demonstrated5 Demonstrated5 Glucosylceramides
CHILD syndrome NAD(P)H 3b-hydroxysteroid
deshydrogenase (NSDHL)
Not assessed Not assessed Not assessed
Niemann-Pick disease Acid sphyngomyelinase Demonstrated6,7 Demonstrated7 Not assessed
1These studies; 2Elias et al. (2004); 3Van den Brink et al. (2004); 4Shibaki et al. (2004); 5Holleran et al. (1994); 6Jensen et al. (1999); 7Schmuth et al. (2000).
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separation has been utilized as a strategy to enhance
transdermal drug delivery. For example, topical neutral
lipid-based penetration enhancers, such as oleic acid, 3-a-
hydroxysterols, and trans-vaccenic acid, form non-lamellar
lipid phases within the SC interstices (Mao-Qiang et al.,
1993; Jiang et al., 2000), producing enhanced transcutaneous
permeability, presumably by a mechanism analogous to the
development of a non-lamellar phase in NLSDI. It is also
likely, but not yet demonstrated, that in several other
inherited, lipid-storage diseases associated with ichthyosis,
such as Refsum disease, Sjo¨gren–Larsson syndrome, and
Congenital Hemidysplasia with Ichthyosiform erythroderma
and Limb Defects (CHILD) syndrome, a similar pathome-
chanism could be operative. An additional pathomechanism
could also be operative in recessive X-linked ichthyosis and
CHILD syndrome; that is, accumulation of lipid precursors
(cholesterol sulfate and desmosterol/zymosterol, respectively)
could result in lamellar membranes that are deficient in
cholesterol. Cholesterol is one of the key lipids (with
ceramides and free fatty acids) that are required to form
mature lamellar membranes, and such cholesterol-deficient
membranes provide a sub-optimal barrier (Feingold, 1991).
In conclusion, the presumed basis for the permeability
barrier abnormality in NLSDI relates to the limited capacity of
lamellar membranes to incorporate excess nonpolar lipids
into lamellar membranes, which already are fully ‘‘loaded’’
with nonpolar species. Yet, it should also be noted that in
most of the inherited disorders where we are positing this
mechanism, neither barrier function nor membrane structure
has been assessed (Table 1).
MATERIALS AND METHODS (see figure legends for further
details)
Patients
The Committee for Human Research, University of California, San
Francisco, approved all the described studies, which were con-
ducted according to the Declaration of Helsinki Principles. All
participants provided formal written, informed consent before their
participation in this study.
We had access to one or more family members from three
unrelated kindreds with NLSDI. The clinical, pathological, and
biochemical abnormalities of the four affected members from the
first kindred (Palestinian) have been described in detail (Elias and
Williams, 1985; Williams et al., 1985; Figure S1).
The affected family member from the second, Greek/Lebanese
kindred (patient no. 1) is a 29-year-old female, who presented with
generalized, fine scaling and hyperkeratosis. She is the only affected
member of a non-consanguineous kindred. Physical examination
showed generalized erythroderma with more severe involvement of
flexural and extensor surfaces, along with prominent hyperkeratosis.
No keratoderma was noted on her palms. Of note, she was
somewhat overweight, with an unusual pattern of fat deposition
over the uppertrunk, face, and neck. Her clinical history began with
a dry and flaky, scaly rash in early infancy when a skin biopsy was
performed that was inconclusive. In addition to clinical finding of an
enlarged liver, associated with repeatedly elevated liver function
tests, a liver biopsy was performed at that time which demonstrated
moderate steatosis with mildly active steatohepatitis. Moreover,
peripheral blood smears showed neutrophils, basophils, and mono-
cytes with multiple, small-to-medium-sized, spherical cytoplasmic
vacuoles. An audiology examination demonstrated sensorineural
hearing loss, while an ophthalmologic evaluation revealed a small
cataract. Her medical history included primary ovarian failure, as
well as type IIa hyperlipoproteinemia. Neither cutaneous nor
respiratory allergies were noted. No other family members were
affected, except for a sister with a history of mild xerosis of the skin
(see pedigree Figure S2b).
When first seen at University of California San Francisco, the
patient’s blood smear demonstrated pale, oil red O-positive vacuoles
within polynuclear leukocytes (Figure 1a), and frozen sections of a
skin biopsy also clearly showed neutral lipid-enriched, cytoplasmic
vacuoles by oil red O staining (Figure 1b). These laboratory findings,
in conjunction with evidence of multisystem involvement, coupled
with an ichthyosiform erythroderma, were considered diagnostic of
NLSDI.
The affected patient from the third, Indian kindred (patient no. 2)
is a 12-year-old girl, who also presented initially with generalized
erythroderma, scaling and xerosis. Physical examination showed
erythroderma with generalized scaling, including the scalp, severe
lichenification of the neck and flexural areas (Figure S2a), and
hyperkeratosis on the extensor aspects of both knees and wrists. The
patient also reported generalized, but moderate pruritus. Her parents
were first cousins (see pedigree: Figure S2c). Family history revealed
no other affected members, but asthma was present in her mother
and grandfathers, and her father had a history of atopic dermatitis
and hay fever. Laboratory testing at the age of 2 years revealed
hypertriglyceridemia, with abnormal liver functions, and a liver
biopsy showed moderate hepatic fibrosis. A blood smear demon-
strated vacuoles in polynucleated leukocytes consistent with stored
neutral lipids, while a skin biopsy again showed lipid inclusions in
epithelial and appendageal keratinocytes. The diagnosis of NLSDI
was therefore confirmed by this characteristic constellation of
clinical and histolopathologic findings.
Methods
We assessed basal permeability barrier function as mean TEWL, with
a Tewameter (Courage and Khazaka, Cologne, FRG) over four
separate sites, which displayed varied clinical features (e.g.,
lichenification), on one patient (patient no. 2), who desisted from
application of topical emollients for 1 week before study. Barrier
function, SC integrity, and cohesion were assessed after sequential
tape-stripping (i.e., repeated application/removal of D-squames
adhesive discs (Cuderm Corp., Dallas, TX, USA)). After aldehyde
pre-fixation of punch biopsies from patient nos. 1 and 2, samples
were split and post-fixed in osmium tetroxide and ruthenium
tetroxide, followed by dehydration and embedding either in an
Epon–epoxy mixture or in lipid-retaining resin-white, a lipid-
retaining epoxy resin (Newman et al., 1983). To further assess and
localize permeability barrier dysfunction by an alternate method,
portions of skin biopsy samples from patient nos. 1 and 2 were
immersed in the water-soluble, electron-dense tracer, 4% colloidal
lanthanum, for 4 hours, followed by osmium tetroxide and ruthe-
nium tetroxide post-fixation and Epon/epoxy embedding, as we have
described (Schmuth et al., 2001, 2004; Elias et al., 2004). Ultrathin
sections were examined and photographed in a Zeiss 10A electron
microscope, operated at 60 kV.
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